FN2 Research
Markets, explained.
Cited, no-noise breakdowns of why stocks move — earnings reactions, macro shifts, and the data behind the headlines.
Two-Front Geopolitical Squeeze: Hormuz Chokehold Meets Chip War Escalation
LNG flows through the Strait of Hormuz are down 95% with vessel traffic at 8 crossings per day, while a 15% US polysilicon tariff and Beijing's broadest retaliation since the Busan truce hit semiconductor and solar supply chains. Monday's market tell: USO +6.7%, XOM +4.4%, CVX +4.5%, SMH -2.3%.
A Flat Close Masks a Violent Rotation: Energy Catches a Hormuz Bid While Semis Slip
The S&P 500 closed barely moved near record highs, but underneath, energy surged over 4% on the unresolved Strait of Hormuz crisis while semiconductors slipped on AI-spending fatigue and Intel's $15B share sale. JPMorgan raised its S&P target to 8,000; BofA warned bullish sentiment is the most extreme since 2021.
Buybacks vs. the Supply Deluge: Can $1.4 Trillion Absorb a Record IPO Wave?
Record equity issuance, the SpaceX lockup, and the AI capex funding gap put Goldman's $1.4 trillion buyback thesis against Ninety One's de-equitisation warning. The summer lull is a breathing window — the real test comes in September.
Three Fronts at Once: Hormuz, Russia Sanctions, and China Retaliation Test Market's Optimism Bias
Oil stocks and crude jumped Monday as three geopolitical risk fronts — Iran's Hormuz standoff, the Senate's 86-11 Russia sanctions bill, and China's tit-for-tat retaliation — collided in the same week, exposing what analysts call the market's "deeply entrenched optimism bias."
Energy Surges, Semis Slip: CPI Looms Over the Record High
Biotech IPO Wave Meets the SpaceX Lockup Test as Options Flows Hit Records
The August IPO market is surging on biotech demand, with four upsized deals raising $1.17 billion in one week. But the real market-structure story is SpaceX's staggered lockup cascade, record options volume, and leveraged ETFs amplifying intraday tech volatility.
Hormuz Deadlock and China's Retaliation Squeeze Markets From Both Ends
Record-High S&P 500 Faces Its CPI Hinge After AI-Earnings Euphoria
Biotech IPOs Lead August as SpaceX Unlock and Reg NMS Overhaul Reshape Market Structure
August 2026 IPO market analysis: biotech-dominated issuance, SpaceX $101B lock-up unlock, SEC Reg NMS trade-through rule rescission proposal, and FINRA best-execution review.
Three Fronts at Once: Why Hormuz, China, and Russian Sanctions Are Converging Into a Single Supply Shock
The market is pricing three geopolitical risks as one: a Hormuz waterway still 75% shut, a US-China trade war entering its sanctions-mirror phase, and a Senate bill that would impose 100% tariffs on buyers of Russian oil. Brent crude settled at $83.55 on Friday, yet energy equities sold off — a divergence that signals demand-destruction fears, not just supply loss.
Record Highs on Shifting Sand: The S&P 500's Strongest Week Since April Papers Over a Jobs Market Gone Quiet
The S&P 500 posted its strongest week since April, up 3.6% to a record close, as Iran de-escalation and strong earnings cleared the market's biggest summer headwinds. But a surprise July payroll decline and a VIX at six-month lows leave the rally sitting on a fault line — with CPI on August 12 as the next test.
August's IPO Market Opens Hot: Biotech Wave, SpaceX Lockup, and Switch's $50B Filing
August's first week delivered the busiest biotech IPO stretch since April — four upsized deals raising $1.17B — while SpaceX's record lockup freed 911M shares and Switch confidentially filed for a data-center mega-IPO potentially approaching $50B.